{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T05:25:25Z","timestamp":1730870725490,"version":"3.28.0"},"reference-count":4,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jaci.2024.07.028","type":"journal-article","created":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T03:14:17Z","timestamp":1726888457000},"page":"1340-1341","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mepolizumab for episodic angioedema with eosinophilia"],"prefix":"10.1016","volume":"154","author":[{"given":"Matthew A.","family":"Rank","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2024.07.028_bib1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jaci.2023.11.002","article-title":"Mepolizumab incompletely suppresses clinical flares in a pilot study of episodic angioedema with eosinophilia","volume":"153","author":"Khoury","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.07.028_bib2","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3389\/fimmu.2018.01198","article-title":"Efficacy and safety of mepolizumab (anti-interleukin 5) treatment in Gleich syndrome","volume":"9","author":"Matucci","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2024.07.028_bib3","first-page":"215","article-title":"Korean adolescent patient with manifestations of lymphocyte variant hypereosinophilic syndrome and episodic angioedema with eosinophilia, treated with reslizumab","volume":"21","author":"Jue","year":"2022","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.07.028_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jaip.2023.10.011","article-title":"Episodic angioedema associated with eosinophilia: benralizumab induced complete remission","volume":"12","author":"Gleich","year":"2024","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924008248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924008248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T12:16:59Z","timestamp":1730809019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674924008248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":4,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0091674924008248"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2024.07.028","relation":{},"ISSN":["0091-6749"],"issn-type":[{"type":"print","value":"0091-6749"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mepolizumab for episodic angioedema with eosinophilia","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2024.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2023.11.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}